» Articles » PMID: 36768307

Epigenetic Regulation of MAP3K8 in EBV-Associated Gastric Carcinoma

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Feb 11
PMID 36768307
Authors
Affiliations
Soon will be listed here.
Abstract

Super-enhancers (SEs) regulate gene expressions, which are critical for cell type-identity and tumorigenesis. Although genome wide H3K27ac profiling have revealed the presence of SE-associated genes in gastric cancer (GC), their roles remain unclear. In this study, ChIP-seq and HiChIP-seq experiments revealed mitogen-activated protein kinase 8 () to be an SE-associated gene with chromosome interactions in Epstein-Barr virus-associated gastric carcinoma (EBVaGC) cells. CRISPRi mediated repression of the SEs attenuated expression and EBVaGC cell proliferation. The results were validated by treating EBVaGC cells with bromodomain and the extra-terminal motif (BET) inhibitor, OTX015. Further, functional analysis of in EBVaGC revealed that silencing could inhibit the cell proliferation, colony formation, and migration of EBVaGC cells. RNA-seq and pathway analysis indicated that knocking down obstructed the notch signaling pathway and epithelial-mesenchymal transition (EMT) in EBVaGC cells. Further, analysis of the cancer genome atlas (TCGA) and GSE51575 databases exhibited augmented expression in gastric cancer and it was found to be inversely correlated with the disease-free progression of GC. Moreover, Spearman's correlation revealed that expression was positively correlated with the expressions of notch pathway and EMT related genes, such as, C-terminal binding protein 2 (), alpha smooth muscle actin isotype 2 (), transforming growth factor beta receptor 1 (), and snail family transcriptional repressors 1/2 (/) in GC. Taken together, we are the first to functionally interrogate the mechanism of SE-mediated regulation of in EBVaGC cell lines.

Citing Articles

C-Terminal Binding Protein: Regulator between Viral Infection and Tumorigenesis.

Huang M, Li Y, Li Y, Liu S Viruses. 2024; 16(6).

PMID: 38932279 PMC: 11209466. DOI: 10.3390/v16060988.


Integrated enhancer regulatory network by enhancer-promoter looping in gastric cancer.

Zhu T, Okabe A, Usui G, Fujiki R, Komiyama D, Huang K NAR Cancer. 2024; 6(2):zcae020.

PMID: 38720882 PMC: 11077903. DOI: 10.1093/narcan/zcae020.


Super enhancer lncRNAs: a novel hallmark in cancer.

Song P, Han R, Yang F Cell Commun Signal. 2024; 22(1):207.

PMID: 38566153 PMC: 10986047. DOI: 10.1186/s12964-024-01599-6.


[Prognostic Value of PCMT1 Expression in Gastric Cancer and Its Regulatory Effect on Spindle Assembly Checkpoints].

Wang Y, Zhang M, Zhang Z, Li B, Huang J, Li J Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 54(6):1167-1175.

PMID: 38162070 PMC: 10752781. DOI: 10.12182/20231160211.

References
1.
Wen D, Wang Y, Zhu Z, Huang Z, Cui L, Wu T . Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(12):165923. DOI: 10.1016/j.bbadis.2020.165923. View

2.
Jia R, Chai P, Zhang H, Fan X . Novel insights into chromosomal conformations in cancer. Mol Cancer. 2017; 16(1):173. PMC: 5693495. DOI: 10.1186/s12943-017-0741-5. View

3.
Kim M, Lee K, Jang H, Kim J, Noh S, Song K . Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion. Mol Cancer Res. 2008; 6(2):222-30. DOI: 10.1158/1541-7786.MCR-07-0142. View

4.
Zhu H, Bengsch F, Svoronos N, Rutkowski M, Bitler B, Allegrezza M . BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression. Cell Rep. 2016; 16(11):2829-2837. PMC: 5177024. DOI: 10.1016/j.celrep.2016.08.032. View

5.
Anggorowati N, Ratna Kurniasari C, Damayanti K, Cahyanti T, Widodo I, Ghozali A . Histochemical and Immunohistochemical Study of α-SMA, Collagen, and PCNA in Epithelial Ovarian Neoplasm. Asian Pac J Cancer Prev. 2017; 18(3):667-671. PMC: 5464482. DOI: 10.22034/APJCP.2017.18.3.667. View